[HTML][HTML] Serotonin transporter: gene, genetic disorders, and pharmacogenetics

DL Murphy, A Lerner, G Rudnick… - Molecular …, 2004 - triggered.edina.clockss.org
The highly evolutionarily conserved serotonin transporter (SERT) regulates the entire
serotoninergic system and its receptors via mod-ulation of extracellular fluid serotonin …

How psychotherapy changes the brain–the contribution of functional neuroimaging

DEJ Linden - Molecular psychiatry, 2006 - nature.com
A thorough investigation of the neural effects of psychotherapy is needed in order to provide
a neurobiological foundation for widely used treatment protocols. This paper reviews …

Attenuation of the neural response to sad faces in major depressionby antidepressant treatment: a prospective, event-related functional magnetic resonance …

CHY Fu, SCR Williams, AJ Cleare… - Archives of general …, 2004 - jamanetwork.com
Background Depression is associated with interpersonal difficulties related to abnormalities
in affective facial processing. Objectives To map brain systems activated by sad facial affect …

Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study

JH Meyer, AA Wilson, S Sagrati… - American Journal of …, 2004 - Am Psychiatric Assoc
OBJECTIVE: Minimum therapeutic doses of paroxetine and citalopram produce 80%
occupancy for the serotonin (5-HT) transporter (5-HTT). The authors used [11C] DASB …

Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial

ML Furey, WC Drevets - Archives of general psychiatry, 2006 - jamanetwork.com
Context The need for improved therapeutic agents that more quickly and effectively treat
depression is critical. In a pilot study we evaluated the role of the cholinergic system in …

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease

SJ Kish, J Tong, O Hornykiewicz, A Rajput, LJ Chang… - Brain, 2008 - academic.oup.com
Interest in serotonergic involvement in Parkinson's disease (PD) has focussed recently on
the possibility that the remaining serotonin neurons innervating striatum (caudate and …

Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders

H Anisman, Z Merali, S Hayley - Progress in neurobiology, 2008 - Elsevier
Given the array of biological changes induced by stressors, it is not surprising that these
experiences may provoke a variety of illnesses. Among others things, stressors promote …

[HTML][HTML] Serotonin and mental disorders: a concise review on molecular neuroimaging evidence

SH Lin, LT Lee, YK Yang - Clinical Psychopharmacology and …, 2014 - ncbi.nlm.nih.gov
Serotonin is one of the most important neurotransmitters influencing mental health and, thus,
is a potential target for pharmaco-logical treatments. Functional neuroimaging techniques …

Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter

CA Stockmeier - Journal of psychiatric research, 2003 - Elsevier
Definitive conclusions on the role of serotonin receptors and transporter in suicide and
depression have been elusive in studies of postmortem brain tissue. A number of …

Treatment of mood disorders

CB Nemeroff, MJ Owens - Nature neuroscience, 2002 - nature.com
Depression is a leading cause of morbidity and mortality, and its treatment includes a high
percentage of the medications prescribed by physicians. Available antidepressant drugs are …